Exposure

• EIC-backed startups are shifting their strategy from passive networking at international trade fairs to converting global exposure into tangible business growth. • The initiative addresses a common industry failure where high-profile corporate meetings and handshakes often result in few concrete outcomes or follow-up deals. • By focusing on structured business development, these startups aim to better leverage their European Innovation Council support to scale across diverse markets including the UK, Germany, and France.

• The FDA has approved the first generic version of baloxavir tablets for the treatment and postexposure prophylaxis of influenza. • The medication is indicated for patients aged 5 years or older, including those who have been exposed to an individual with the flu. • This approval is based on the generic product meeting regulatory standards for equivalence to the reference listed drug rather than new clinical efficacy data.

Research finds immune systems still ‘responding to toxic chemical exposures’ related to East Palestine derailmentIn the weeks after the East Palestine train wreck culminated in a towering fireball and chemical release in the small Ohio town, Jessica Boersma was seriously exposed to the stew of compounds emitted from the derailment site.Boersma lives less than a quarter mile away, and, as a city council member, she had to spend significant time at the site coordinating with first responders. Continue reading...

• Chinese investors are increasingly using digital assets and synthetic instruments to gain exposure to high-profile U.S. tech IPOs. • These maneuvers allow traders to bypass traditional regulatory hurdles and capital controls to invest in lucrative Western technology markets. • The trend underscores the high demand for U.S. growth assets among Chinese traders, despite the significant financial and legal risks involved.

• Energy markets reacted sharply to escalating tensions in the Middle East, with Brent crude rising to approximately $97 per barrel and U.S. oil trading between $94 and $95. • The price surge, representing a jump of more than 4.5%, indicates that traders are rapidly reintroducing a geopolitical risk premium into oil valuations. • This volatility reflects a "new normal" where Iran employs a stop-start strategy, transforming intermittent security risks into a structural feature of global markets.

• The FDA has approved the oral antiviral ensitrelvir (Xocova), developed by Shionogi & Co, Ltd, for post-exposure prophylaxis (PEP) of COVID-19. • The treatment is authorized for use in adults and adolescents aged 12 years and older to prevent symptomatic SARS-CoV-2 infection. • Approval was based on the SCORPIO-PEP phase 3 trial, which demonstrated the drug's safety and efficacy in household contacts of symptomatic patients.

• The U.S. FDA has approved ensitrelvir (Xocova), an oral antiviral developed by Shionogi, for the post-exposure prevention of COVID-19. • The medication is authorized for use in individuals aged 12 years and older who have been exposed to the SARS-CoV-2 virus. • This approval is significant as Xocova becomes the first and only oral medication specifically authorized to reduce the risk of infection after a known exposure.